Scope Fluidics
Scope Fluidics S.A. is a biotechnology company engaged in designing and developing innovative projects based on microfluidic technologies in medical diagnostics and healthcare. The company focuses on creating fast, effective, and accessible medical diagnostics to improve treatment quality and reduce hospitalization costs. It owns a special-purpose vehicle, Bacteromic Sp. z o.o., to develop diagnostic systems like BACTEROMIC for assessing drug susceptibility of microorganisms, and PCR|ONE for rapid disease diagnosis. The company's operating model involves devising innovative projects, developing them within special-purpose vehicles, and selling them to global entities. Scope Fluidics is listed on the Warsaw Stock Exchange and aims to develop diagnostic systems that address societal needs for better healthcare.
Industries
Nr. of Employees
medium (51-250)
Products
Antibiotic susceptibility testing (AST) diagnostic system
A microfluidic diagnostic system designed to rapidly determine antibiotic resistance profiles of bacterial isolates, provide quantitative susceptibility results across clinically relevant antibiotics, and identify synergistic antibiotic pairs.
Ultra-fast PCR molecular diagnostic system
A rapid PCR-based diagnostic platform and associated genetic tests developed for fast detection of viral and bacterial pathogens, including validated assays for SARS-CoV-2.
Microfluidic PCR cartridge production capability
In-house production capability and manufacturing line for producing microfluidic PCR chips used by molecular diagnostic platforms.
Antibiotic susceptibility testing (AST) diagnostic system
A microfluidic diagnostic system designed to rapidly determine antibiotic resistance profiles of bacterial isolates, provide quantitative susceptibility results across clinically relevant antibiotics, and identify synergistic antibiotic pairs.
Ultra-fast PCR molecular diagnostic system
A rapid PCR-based diagnostic platform and associated genetic tests developed for fast detection of viral and bacterial pathogens, including validated assays for SARS-CoV-2.
Microfluidic PCR cartridge production capability
In-house production capability and manufacturing line for producing microfluidic PCR chips used by molecular diagnostic platforms.
Services
End-to-end diagnostic product development
Development services from concept and prototyping to technology design, clinical validation and preparation for industrialisation.
Prototype fabrication and pre-production manufacturing support
Prototyping and small-scale manufacturing support using micro-machining and injection molding, and operation of manufacturing lines for microfluidic cartridges.
Clinical and certification testing services
Execution of clinical tests, laboratory validation and certification-panel testing for diagnostic panels and device preregistration activities.
Intellectual property and patent support
Preparation of patent application documentation, patentability assessment and building of IP portfolios for innovations in diagnostics.
Commercialization and partnership facilitation
Support for establishing strategic relationships with global diagnostic operators and for the transfer or sale of developed projects via SPV structures.
End-to-end diagnostic product development
Development services from concept and prototyping to technology design, clinical validation and preparation for industrialisation.
Prototype fabrication and pre-production manufacturing support
Prototyping and small-scale manufacturing support using micro-machining and injection molding, and operation of manufacturing lines for microfluidic cartridges.
Clinical and certification testing services
Execution of clinical tests, laboratory validation and certification-panel testing for diagnostic panels and device preregistration activities.
Intellectual property and patent support
Preparation of patent application documentation, patentability assessment and building of IP portfolios for innovations in diagnostics.
Commercialization and partnership facilitation
Support for establishing strategic relationships with global diagnostic operators and for the transfer or sale of developed projects via SPV structures.
Expertise Areas
- Microfluidic diagnostics (lab-on-chip)
- Molecular diagnostics and rapid PCR assays
- Phenotypic antibiotic susceptibility testing (AST)
- Clinical validation and pre-registration testing
Key Technologies
- Microfluidics (lab-on-chip)
- Rapid PCR / point-of-care PCR
- Polymer microfabrication (injection molding, micro-machining)
- Microfluidic PCR cartridges (chips)